SERAHIGH SIGNALFINANCIAL10-K

SERA shows concerning operational deterioration with operating cash flow burn increasing 81% to $25.6M despite reduced R&D spending, though balance sheet strength improved significantly through equity raises.

The dramatic increase in cash burn alongside declining current assets creates a concerning trajectory for runway sustainability, despite the company raising substantial equity capital. The widening gap between spending and operational efficiency suggests execution challenges in commercializing their pregnancy diagnostics platform.

Comparing 2026-03-18 vs 2025-03-19View on EDGAR →
FINANCIAL ANALYSIS

SERA's financial profile shows mixed signals with significant balance sheet strengthening through equity financing (stockholders' equity up 58% to $75.4M and total assets up 41% to $101.9M) contrasted against severely deteriorating operations (operating cash flow burn worsened 81% to $25.6M). Despite reducing R&D expenses by 11% to $13.2M, the company's cash consumption accelerated dramatically while current assets declined 14%, suggesting inefficient capital deployment and potential challenges in achieving commercial traction for their women's health diagnostics platform.

FINANCIAL STATEMENT CHANGES
Capital Expenditure
Cash Flow
+1196.4%
$56K→$726K

Capital expenditure jumped 1196.4% — major investment cycle underway; assess returns on deployment.

Operating Cash Flow
Cash Flow
-80.6%
-$14.2M→-$25.6M

Operating cash flow fell 80.6% — earnings quality concerns; investigate working capital changes and non-cash items.

Interest Expense
P&L
-67.9%
$28K→$9K

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Accounts Receivable
Balance Sheet
-64.7%
$34K→$12K

Receivables declined — improved collection efficiency or conservative revenue recognition.

Stockholders Equity
Balance Sheet
+57.7%
$47.8M→$75.4M

Equity base grew 57.7% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Total Assets
Balance Sheet
+40.5%
$72.6M→$101.9M

Asset base grew 40.5% — expansion through organic growth, acquisitions, or capital deployment.

Current Assets
Balance Sheet
-14.3%
$47.6M→$40.8M

Current assets declined 14.3% — monitor working capital adequacy and short-term liquidity.

R&D Expense
P&L
-10.6%
$14.7M→$13.2M

R&D spending cut 10.6% — could signal cost discipline or concerning reduction in innovation investment.

LANGUAGE CHANGES
NEW — 2026-03-18
PRIOR — 2025-03-19
ADDED
As of March 13, 2026 , the registrant had 38,176,089 and 967,759 shares of Class A and B common stock, $0.0001 par value per share, outstanding, respectively.
Form 10-K Summary 131 Signatures 132 Sera, PreTRM, PreTRM Global, The Pregnancy Company, Sera Prognostics, LikeMine, and our logo are our trademarks.
Our vision is to become the global leader in high-value women s health diagnostics.
We plan to do this by taking a holistic approach to providing pivotal and actionable information to pregnant women, their physicians, and health care payers to significantly enhance a mother s pregnancy journey, improve maternal and neonatal health, and reduce health care costs.
The 2025 March of Dimes Report Card shows that, for the fourth consecutive year, the United States earned a D+ grade for preterm birth, making the longest stretch of the lowest grade in Report Card history.
+7 more — sign up free →
REMOVED
As of March 14, 2025, the registrant had 36,695,803 and 967,759 shares of Class A and B common stock, $0.0001 par value per share, outstanding, respectively.
Form 10-K Summary 129 Signatures 130 Sera, PreTRM, The Pregnancy Company and our logo are our trademarks.
Our vision is to deliver pivotal and actionable information to pregnant women, their physicians, and health care payers to significantly enhance a mother s pregnancy journey, improve maternal and neonatal health, and reduce health care costs.
In many cases these complications have profound short- and long-term health consequences for the mother and baby.
These health consequences of preterm birth alone are estimated to be approximately $25 billion annually in the United States.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →